Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BILLEV PHARMA ApS
APS
Active
Advertising protection
CVR 81814813
Slotsmarken 10, 2970
Hørsholm
All other professional, scientific and technical activities n.e.c.
· NACE 7499
Est. 1977 · 48 years old
29 employees
Monitor
Share
Denmark
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
BILLEV PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
9M
18M
27M
36M
26M
2021
30M
2022
29M
2023
25M
2024
31M
2025
EBITDA
DKK millions
10M
8M
5M
3M
0M
7M
2021
8M
+14%
2022
6M
-25%
2023
4M
-33%
2024
8M
+100%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
25.638
30.171
29.073
24.763
31.189
Staff expenses
-15.913
-19.409
-19.348
-17.384
-19.493
EBITDA
7.120
7.761
6.394
4.357
7.923
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
7.120
7.761
6.394
4.357
7.923
Net financials
0
-41
-52
-15
-19
Profit before tax
7.120
7.721
6.342
4.342
7.904
Tax
1.571
1.707
1.399
963
1.760
Net profit
5.549
6.013
4.943
3.379
6.144
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
9.366
10.362
8.946
6.911
12.280
Equity
5.869
6.333
5.263
3.699
6.464
Long-term debt
347
1.451
1.362
607
260
Short-term debt
3.051
2.461
2.234
2.532
5.495
Total debt
3.397
3.912
3.595
3.139
5.755
Financial ratios
5-year trend
EBITDA margin (of gross profit)
25.4%
This company
2021
2025
Equity ratio
52.6%
This company
38.2%
Market median
+38% vs market
2021
2025
Return on equity
95.0%
This company
18.4%
Market median
+416% vs market
2021
2025
Net profit margin (of gross profit)
19.7%
This company
2021
2025
Asset turnover (of gross profit)
2.54×
This company
2021
2025
Debt / equity
0.90×
This company
0.62×
Market median
+45% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
View
PDF
More on BILLEV PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
